| 12178592 |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I |
Beth McQuiston, Frederick Korley, Agim Beshiri, Jaime Marino |
2024-12-31 |
$97,931,000 |
| 12163958 |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1 |
Beth McQuiston, Justin Rogers, Jaime Marino |
2024-12-10 |
$238,374,000 |
| 12123883 |
Methods for measuring ubiquitin carboxy—terminal hydrolase L1 levels in blood |
Gangamani S. Beligere, Melissa B. Brennan, Jessica Grieshaber, David Pacenti, John M. Ramp |
2024-10-22 |
$161,478,000 |
| 12105098 |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) |
Beth McQuiston, Raj Chandran |
2024-10-01 |
$142,760,000 |
| 12105100 |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1 |
Beth McQuiston, Raj Chandran, Jaime Marino |
2024-10-01 |
$142,760,000 |
| 12099069 |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers |
Beth McQuiston, Justin Rogers, Jaime Marino |
2024-09-24 |
$193,354,000 |
| 12092647 |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers |
Beth McQuiston, Justin Rogers, Jaime Marino, Raj Chandran, Tianming Zhang |
2024-09-17 |
$463,116,000 |
| 12085567 |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject |
Beth McQuiston, Justin Rogers, Jaime Marino |
2024-09-10 |
$162,375,000 |
| 11994523 |
Biomarkers and methods for diagnosing and evaluating traumatic brain injury |
Jennifer E. Van Eyk, Beth McQuiston, Raj Chandran, Vidya Venkatraman, Shenyan Zhang |
2024-05-28 |
$129,145,000 |
| 11931161 |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers |
Beth McQuiston, Frederick Korley, Agim Beshiri, Jaime Marino |
2024-03-19 |
$214,961,000 |
| 11169159 |
Methods for measuring ubiquitin carboxy-terminal hydrolase L1 levels in blood |
Gangamani S. Beligere, Melissa B. Brennan, Jessica Grieshaber, David Pacenti, John M. Ramp |
2021-11-09 |
$302,080,000 |
| 11129564 |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I |
Beth McQuiston, Frederick Korley, Agim Beshiri, Jaime Marino |
2021-09-28 |
$229,474,000 |
| 11022617 |
Methods for aiding in the diagnosis and evaluation of a subject who has sustained an orthopedic injury and that has or may have sustained an injury to the head, such as mild traumatic brain injury (TBI), using glial fibrillary acidic protein (GFAP) and/or ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) |
Beth McQuiston, Raj Chandran |
2021-06-01 |
$479,342,000 |
| 11016105 |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of GFAP and UCH-L1 |
Beth McQuiston, Raj Chandran, Jaime Marino |
2021-05-25 |
$134,850,000 |
| 11016092 |
Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase L1 |
Beth McQuiston, Justin Rogers, Jaime Marino |
2021-05-25 |
$134,850,000 |
| 10877038 |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject |
Beth McQuiston, Justin Rogers, Jaime Marino |
2020-12-29 |
$257,992,000 |
| 10877048 |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers |
Beth McQuiston, Justin Rogers, Jaime Marino |
2020-12-29 |
$257,992,000 |
| 10866251 |
Methods for aiding in the determination of whether to perform imaging on a human subject who has sustained or may have sustained an injury to the head using early biomarkers |
Beth McQuiston, Justin Rogers, Jaime Marino, Raj Chandran, Tianming Zhang |
2020-12-15 |
$247,577,000 |
| 10849548 |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I and early biomarkers |
Beth McQuiston, Frederick Korley, Agim Beshiri, Jaime Marino |
2020-12-01 |
$609,739,000 |
| 8741287 |
PlGF-1 assay and kits and components thereof |
Susan E. Brophy, Lianli Chi, David J. Hawksworth, Don M. Laird, Sharmila Manoj +8 more |
2014-06-03 |
$18,127,000 |
| 8658384 |
Biomarkers for prediction of major adverse cardiac events and uses thereof |
Jessie W. Shih, Robert C. Doss, Walter J. Keirans, Sudarshan Hebbar |
2014-02-25 |
$20,197,000 |
| 8501420 |
Biomarkers for prediction of major adverse cardiac events and uses thereof |
Jessie W. Shih, Robert C. Doss, Walter J. Keirans, Sudarshan Hebbar |
2013-08-06 |
$13,550,000 |
| 8349325 |
Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
Susan E. Brophy, David J. Hawksworth, Don C. Laird, Sharmila Manoj, Dominick L. Pucci +3 more |
2013-01-08 |
$26,270,000 |
